BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao C. Lipid Nanoparticles for Drug Delivery. Advanced NanoBiomed Research 2022;2:2100109. [DOI: 10.1002/anbr.202100109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Karunakaran B, Gupta R, Patel P, Salave S, Sharma A, Desai D, Benival D, Kommineni N. Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines 2023;11:661. [DOI: 10.3390/vaccines11030661] [Reference Citation Analysis]
2 Kafetzis KN, Papalamprou N, McNulty E, Thong KX, Sato Y, Mironov A, Purohit A, Welsby PJ, Harashima H, Yu-Wai-Man C, Tagalakis AD. The Effect of Cryoprotectants and Storage Conditions on the Transfection Efficiency, Stability, and Safety of Lipid-Based Nanoparticles for mRNA and DNA Delivery. Adv Healthc Mater 2023;:e2203022. [PMID: 36906918 DOI: 10.1002/adhm.202203022] [Reference Citation Analysis]
3 Subroto E, Andoyo R, Indiarto R. Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds. Antioxidants 2023;12:633. [DOI: 10.3390/antiox12030633] [Reference Citation Analysis]
4 Akombaetwa N, Ilangala AB, Thom L, Memvanga PB, Witika BA, Buya AB. Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. Pharmaceutics 2023;15. [PMID: 36839978 DOI: 10.3390/pharmaceutics15020656] [Reference Citation Analysis]
5 Seo H, Jeon L, Kwon J, Lee H. High-Precision Synthesis of RNA-Loaded Lipid Nanoparticles for Biomedical Applications. Adv Healthc Mater 2023;:e2203033. [PMID: 36737864 DOI: 10.1002/adhm.202203033] [Reference Citation Analysis]
6 Huang SY, Yeh NT, Wang TH, Hsu TC, Chin HY, Tzang BS, Chiang WH. Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy. Int J Biol Macromol 2023;227:925-37. [PMID: 36563808 DOI: 10.1016/j.ijbiomac.2022.12.172] [Reference Citation Analysis]
7 Bhaladhare S, Bhattacharjee S. Chemical, physical, and biological stimuli-responsive nanogels for biomedical applications (mechanisms, concepts, and advancements): A review. Int J Biol Macromol 2023;226:535-53. [PMID: 36521697 DOI: 10.1016/j.ijbiomac.2022.12.076] [Reference Citation Analysis]
8 Kim M, Lee NK, Wang CJ, Lim J, Byun MJ, Kim TH, Park W, Park DH, Kim SN, Park CG. Reprogramming the tumor microenvironment with biotechnology. Biomater Res 2023;27:5. [PMID: 36721212 DOI: 10.1186/s40824-023-00343-4] [Reference Citation Analysis]
9 Moon Y, Jeon SI, Shim MK, Kim K. Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy. Pharmaceutics 2023;15. [PMID: 36839734 DOI: 10.3390/pharmaceutics15020411] [Reference Citation Analysis]
10 Hughes KA, Misra B, Maghareh M, Bobbala S. Use of stimulatory responsive soft nanoparticles for intracellular drug delivery. Nano Res 2023;:1-17. [PMID: 36685637 DOI: 10.1007/s12274-022-5267-5] [Reference Citation Analysis]
11 Marques AC, Costa PC, Velho S, Amaral MH. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 2023;15. [PMID: 36678845 DOI: 10.3390/pharmaceutics15010216] [Reference Citation Analysis]
12 Thirupathi K, Phan TTV, Santhamoorthy M, Ramkumar V, Kim SC. pH and Thermoresponsive PNIPAm-co-Polyacrylamide Hydrogel for Dual Stimuli-Responsive Controlled Drug Delivery. Polymers (Basel) 2022;15. [PMID: 36616517 DOI: 10.3390/polym15010167] [Reference Citation Analysis]
13 Almatroudi A, Alsahli MA, Syed MA, Khan AA, Rahmani AH. Regulation of Pro-Inflammatory Macrophage Polarization via Lipid Nanoparticles Mediated Delivery of Anti-Prostaglandin-E2 siRNA. Curr Issues Mol Biol 2022;45:1-11. [PMID: 36661487 DOI: 10.3390/cimb45010001] [Reference Citation Analysis]
14 Li Y, Yang G, Gerstweiler L, Thang SH, Zhao C. Design of Stimuli‐Responsive Peptides and Proteins. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202210387] [Reference Citation Analysis]
15 Jampilek J, Kralova K. Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. Pharmaceutics 2022;14. [PMID: 36559200 DOI: 10.3390/pharmaceutics14122706] [Reference Citation Analysis]
16 Mohammadpour F, Kamali H, Gholami L, McCloskey AP, Kesharwani P, Sahebkar A. Solid lipid nanoparticles: a promising tool for insulin delivery. Expert Opin Drug Deliv 2022;19:1577-95. [PMID: 36287584 DOI: 10.1080/17425247.2022.2138328] [Reference Citation Analysis]
17 Kalita T, Dezfouli SA, Pandey LM, Uludag H. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases. Pharmaceutics 2022;14. [PMID: 36432711 DOI: 10.3390/pharmaceutics14112520] [Reference Citation Analysis]
18 Chibh S, Suyal S, Aggarwal N, Bachhawat AK, Panda JJ. Cysteine-phenylalanine-derived self-assembled nanoparticles as glutathione-responsive drug-delivery systems in yeast. J Mater Chem B 2022;10:8733-43. [PMID: 36250485 DOI: 10.1039/d2tb01362b] [Reference Citation Analysis]
19 Tian Q, Guo Y, Li D, Dong L. Hybrid Gastric Cancer Exosome as Potential Drug Carrier for Targeted Gastric Cancer Therapy. j biomater tissue eng 2022;12:2228-2232. [DOI: 10.1166/jbt.2022.3167] [Reference Citation Analysis]
20 Ren R, Lim C, Li S, Wang Y, Song J, Lin T, Muir BW, Hsu H, Shen H. Recent Advances in the Development of Lipid-, Metal-, Carbon-, and Polymer-Based Nanomaterials for Antibacterial Applications. Nanomaterials 2022;12:3855. [DOI: 10.3390/nano12213855] [Reference Citation Analysis]
21 Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics 2022;14:2135. [PMID: 36297570 DOI: 10.3390/pharmaceutics14102135] [Reference Citation Analysis]
22 Chen C, Chen C, Li Y, Gu R, Yan X. Characterization of lipid-based nanomedicines at the single-particle level. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.09.011] [Reference Citation Analysis]
23 Leong EWX, Ge R. Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. Biomedicines 2022;10:2179. [DOI: 10.3390/biomedicines10092179] [Reference Citation Analysis]
24 Ishimoto A, Sasako H, Omori M, Higashi K, Ueda K, Koyama K, Moribe K. Drug-Loaded Nanocarriers Composed of Cholesteryl Oleate Crystal Cores and Multiple-Nanosheet Shells of γ-Cyclodextrin Inclusion Complex Crystals. Langmuir 2022. [PMID: 35976036 DOI: 10.1021/acs.langmuir.2c01199] [Reference Citation Analysis]
25 Zhang Z, Yao S, Hu Y, Zhao X, Lee RJ. Application of lipid-based nanoparticles in cancer immunotherapy. Front Immunol 2022;13:967505. [DOI: 10.3389/fimmu.2022.967505] [Reference Citation Analysis]
26 Karthika C, Najda A, Klepacka J, Zehravi M, Akter R, Akhtar MF, Saleem A, Al-shaeri M, Mondal B, Ashraf GM, Tagde P, Ramproshad S, Ahmad Z, Khan FS, Rahman MH. Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach. Molecules 2022;27:4663. [DOI: 10.3390/molecules27144663] [Reference Citation Analysis]
27 Akbari J, Saeedi M, Ahmadi F, Hashemi SMH, Babaei A, Yaddollahi S, Rostamkalaei SS, Asare-addo K, Nokhodchi A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology. [DOI: 10.1080/10837450.2022.2084554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]